Submitted by sg999 on
CMS-CCSQ Support for Medication data elements for USCDI v3
CMS-CCSQ recommend the following Medication data elements be added to USCDI V3:
- Data Element: Medication Administration; defined as a code (or set of codes) that specifies the medication administered to a patient.
- Data Element: Discharge Medications; specifies the medication(s) active at discharge which should be taken by the patient upon release from a facility.
- Data Element: Medications Dispensed; defined as a code (or set of codes) that specifies the medication dispensed
- Data Element: Medication Dosage (and Route); defined as the dose and route instructions for medications
- Data Element: Medication Negation Rationale; defined as the reason a medication was not ordered/administered
Rationale: CMS recommends adding more specificity to the USCDI Medications Data Class because interoperability of medication information and management of medications is critical to ensure patients receive appropriate and safe care. The current concept of medications in USCDI does not differentiate among medications that are active, ordered, and actually administered/dispensed to the patient. Given these complexities, more clarity and structure are necessary in this data class to accurately evaluate and provide clinical care. Additionally, the currently required data lack important clinical specificity (dosage and route instructions). Finally, the reason a medication was not given (negation rationale) provides important context for clinical care and patient engagement and improves patient-provider communication when this information travels with the patient across care settings. These additional medication details are critical to contextualize a medication and ensure patients and clinicians understand the mediations necessary for a patient, and how those should be taken, throughout the continuum of care. These detailed medication data are used extensively in quality measurement and are routinely exchanged when prior authorization is required.
Maturity:
- Current standards:
- In FHIR US Core, there is a distinction between "Medication" and "Medication Request”; base FHIR and FHIR QI Core IG includes "Medication Administration" and “Medication Dispensed” profiles.
- Within Medication Request, the ‘category’ is used to define discharge medications.
- Dose and route instructions are also contextualized within the Medication Request, Medication Administration, and Medication Dispense profiles in US/QI Core IGs.
- Negation details are expressed within the status reason (for not done) in Medication Request profile and Not Done profiles within QI Core.
- Current uses, exchange, and use cases: Medication data is routinely captured in EHR systems used by hospitals, providers, and other healthcare stakeholders including pharmacies. Medication details are routinely exchanged across providers and payers. Medication data is used extensively in CMS quality measurement. Additionally, when prior authorization is necessary for a medication, details related to the medication (e.g., why the medication is given, the quantity needed) are exchanged to support the approval process.
Submitted by sg999 on
CMS-CCSQ Continued Support of Medication data elements: USCDI v3
Management of medications is critical to patient care and coordination between providers, as well as related quality and public health enterprises. The current concept of medications in USCDI Draft version 3 does not differentiate those that are active, ordered, or actually administered to the patient, and do not provide necessary details for patient safety (i.e., dose and route). Medication details support an ONC criteria for public health reporting and investigation including using data to support safer use of opioids.
CMS-CCSQ recommend the following Medication data elements be added to Final USCDI v3:
Maturity: